Regeneron Pharmaceuticals
REGN
$974.64
Share price
-0.36%
Change (1 day)
29.79%
Change (1 year)
Categories
Regeneron Pharmaceuticals (REGN) - Net assets
Net assets on the balance sheet as of March 2024 : $26.99 B
According to Regeneron Pharmaceuticals's latest financial reports the company has $26.99 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Regeneron Pharmaceuticals - Net assets on balance sheet (from 2001 to 2024)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $25.97 B | 14.6% |
| 2022-12-31 | $22.66 B | 20.75% |
| 2021-12-31 | $18.76 B | 70.23% |
| 2020-12-31 | $11.02 B | -0.58% |
| 2019-12-31 | $11.08 B | 26.63% |
| 2018-12-31 | $8.75 B | 42.53% |
| 2017-12-31 | $6.14 B | 38.09% |
| 2016-12-31 | $4.44 B | 21.74% |
| 2015-12-31 | $3.65 B | 43.31% |
| 2014-12-31 | $2.55 B | 30.64% |
| 2013-12-31 | $1.95 B | 56.74% |
| 2012-12-31 | $1.24 B | 156.39% |
| 2011-12-31 | $0.48 B | -7.97% |
| 2010-12-31 | $0.52 B | 33.03% |
| 2009-12-31 | $0.39 B | -5.87% |
| 2008-12-31 | $0.42 B | -8.42% |
| 2007-12-31 | $0.46 B | 112.47% |
| 2006-12-31 | $0.21 B | 90.02% |
| 2005-12-31 | $0.11 B | -37.55% |
| 2004-12-31 | $0.18 B | 32.62% |
| 2003-12-31 | $0.13 B | -5.71% |
| 2002-12-31 | $0.14 B | -45.19% |
| 2001-12-31 | $0.26 B |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $70.02 B | 159.42% | 🇺🇸 USA |
 Novartis NVS | $39.75 B | 47.29% | 🇨🇭 Switzerland |
 Amgen AMGN | $6.23 B | -76.91% | 🇺🇸 USA |
 Sanofi SNY | $82.20 B | 204.56% | 🇫🇷 France |
 Biogen BIIB | $15.21 B | -43.64% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$0.22 B | -100.81% | 🇺🇸 USA |